© Reuters. FILE PHOTO: An Apple Store employee shows the new Series 5 Apple Watch during the preview of the redesigned and reimagined Apple Fifth Avenue store in New York, U.S., September 19, 2019. REUTERS/Brendan McDermid/File Photo
(Reuters) – A U.S. judge ruled that Apple (NASDAQ:) had infringed on one of Masimo Corp’s pulse oximeter patents by importing and selling certain Apple Watches with light-based pulse oximetry functionality and components, Masimo (NASDAQ:) said on Tuesday.
The United States International Trade Commission (USITC) will now consider whether to implement an import ban on these Apple Watches, the medical device maker said.
Image and article originally from www.investing.com. Read the original article here.